輸入代號或公司名稱後按 Enter
4120

友華

+1.10 (+2.39%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
47.102成交張數本益比0.78股價淨值比8.49%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q2-2.11-6.64-1.83-15.4%-3.36%-10.08%
2026Q1-0.29-5.06-0.25-2.2%-0.42%-7.85%
2025Q4-2.76-6.54-2.39-20.0%-3.64%-9.91%
2025Q3-1.48-1238.5%-5.33-1.29-11.6%-1.97%-7.67%
2025Q2-0.53-3.72-0.46-4.1%-0.78%-5.62%
2025Q1-1.77-4.00-1.54-13.3%-2.88%-7.51%
2024Q4-1.55-139.5%-3.27-1.35-11.9%-2.60%-6.54%
2024Q30.132.200.111.1%0.22%4.36%
2024Q2-0.811.67-0.71-6.5%-1.56%3.40%
2024Q1-1.04-425.0%0.30-0.90-8.1%-2.47%0.77%
2023Q43.921.663.4028.0%9.64%4.47%
2023Q3-0.40-2.83-0.35-3.2%-1.03%-7.62%
2023Q2-2.18-4.59-1.89-16.7%-6.01%-12.92%
2023Q10.3218.5%-3.530.282.4%0.93%-10.02%
2022Q4-0.57-129.4%-3.58-0.50-3.9%-1.70%-10.59%
2022Q3-2.16-1.07-1.87-17.0%-6.41%-3.27%
2022Q2-1.120.55-0.97-8.1%-3.24%1.60%
2022Q10.27285.7%1.590.242.1%0.78%4.41%
2021Q41.941.391.6813.1%5.88%3.91%
2021Q3-0.54-0.94-0.47-4.1%-1.64%-2.69%
2021Q2-0.08-105.4%-0.55-0.07-0.6%-0.21%-1.52%
2021Q10.07-94.8%1.010.060.5%0.18%2.67%
2020Q4-0.39-200.0%2.30-0.34-2.5%-1.03%6.23%
2020Q3-0.15-141.7%3.08-0.13-1.1%-0.40%8.14%
2020Q21.48142.6%3.591.289.5%3.86%9.46%
2020Q11.36-9.3%2.721.187.6%3.63%7.00%
2019Q40.3985.7%2.860.332.1%1.03%7.65%
2019Q30.36-62.9%2.680.312.1%0.96%7.14%
2019Q20.61408.3%3.290.533.5%1.61%8.91%
2019Q11.50-2.6%2.801.308.6%3.86%7.12%
2018Q40.2140.0%2.840.191.3%0.57%7.53%
2018Q30.97-48.4%2.780.846.1%2.59%7.33%
2018Q20.12-90.3%3.690.100.7%0.30%10.04%
2018Q11.54-23.8%4.811.349.8%4.03%12.67%
2017Q40.15-90.6%5.290.131.0%0.40%14.31%
2017Q31.88100.0%6.741.6312.1%5.05%18.57%
2017Q21.2442.5%5.801.088.7%3.39%16.36%
2017Q12.021.0%5.431.7513.2%5.51%14.93%
2016Q41.605.411.4010.2%4.53%
2016Q30.940.816.4%2.70%